Pharma Business

PharmaBusiness

The US generic pharma industry operates in a competitive landscape driven by market forces, regulatory requirements, legal challenges and pricing pressures.

The industry growth is fueled by the need of affordable medicines, patent expiration and government policies promoting generic drug usage.

Biosimilars are introducing increased competition, cost savings and market expansion. However full impact of biosimilars on market dynamics is still evolving as more biosimilars gain approvals and enter the market.

Policy changes in the US generics pharmaceutical industry can have both positive and negative effects. While policy changes aim to promote competition, affordability and access to generic drugs, they also introduce risks and potential shortages

August 8, 2024

New Product Planning

Genomic Research in Pharma Business: Unlocking the discovery of Personalized Medicines​

August 8, 2024

Strategic Marketing

Pharma Business Marketing Tech Stack: Cutting-Edge Technologies empower pharmacos to optimize their Marketing and Sales Effectiveness

New Posts

Genomic Research in Pharma Business: Unlocking the discovery of Personalized Medicines​

Pharma Business Marketing Tech Stack: Cutting-Edge Technologies empower pharmacos to optimize their Marketing and Sales Effectiveness

Herbal Medicines Efficacy and Safety hinges on the Quality of Herbal Extracts

Organisation Turnaround Mindset in Pharma Business: Strategies which deliver sustained high growth in Revenues and EBITDA

Strategic Benchmarking: When you benchmark best practices not just from your industry … but also from other industries